Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01395082 · ClinicalTrials.gov registry record
ACAM2000® Myopericarditis Registry
A clinical trial, sponsored by Emergent BioSolutions.
- Completed
- Registry status
- 24
- Enrollment target
NCT01395082 is a clinical trial that has completed, run by Emergent BioSolutions. The registered enrollment target is 24 participants.
The verdict
NCT01395082 has completed, sponsored by Emergent BioSolutions.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this registry is to study the natural history of vaccination-related myocarditis and pericarditis and to assess possible risk factors for these conditions. Primary Objective: \- To document the natural history of confirmed, probable, suspected, and subclinical myocarditis and pericarditis (myopericarditis) following ACAM2000® vaccination. Other Pre-defined Objective: \- To look for potential predictive factors for the prognosis of myopericarditis following ACAM2000® vaccination.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-04 |
| Est. Completion | 2019-02-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01395082
The ClinicalTrials.gov registry entry for NCT01395082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emergent BioSolutions, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01395082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01395082 about?
NCT01395082 is a clinical study titled "ACAM2000® Myopericarditis Registry". The purpose of this registry is to study the natural history of vaccination-related myocarditis and pericarditis and to assess possible risk factors for these conditions. Primary Objective: \- To document the natural history of confirmed, probable, suspected, and subclinical myocarditis and perica...
What is the current status of trial NCT01395082?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2011-04. Estimated completion is 2019-02-04.
Who is sponsoring clinical trial NCT01395082?
This trial is sponsored by Emergent BioSolutions, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.